Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04753476
Recruitment Status : Recruiting
First Posted : February 15, 2021
Last Update Posted : February 17, 2021
Sponsor:
Collaborator:
Provincial Government of Central Java, Indonesia
Information provided by (Responsible Party):
Agung Putra, Stem Cell and Cancer Research Indonesia

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 8, 2021
Estimated Study Completion Date : August 8, 2021
Publications of Results:
Other Publications: